Multiple Myeloma – Sagar Lonial, MD, and Robert Figlin, MD, discuss clinical highlights from ASH 2018

Wednesday December 12, 2018

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Sagar Lonial, MD, Professor and Chair, Hematology & Medical Oncology, Chief Medical Officer, Winship Cancer Institute of Emory University, discuss ALCYONE, GRIFFIN, and maintenance therapy (TOURMALINE-MM3), and other multiple myeloma clinical studies presented at the American Society of Hematology 2018 meeting

Featured Videos

Ahmed Kaseb, MD, on the differentiation of levatinib vs cabozantinib for HCC treatment

Daneng Li, MD, on combining cabozantinib with checkpoint inhibitors to improve patient outcomes

Daneng Li, MD, regarding the role of immunotherapy in the neoadjuvant and adjuvant setting for HCC